Ajani explained HB 20-85 would prohibit physicians and health professionals from providing gender-transition procedures or referrals for individuals under 18, bar use of public funds for such procedures to minors, prohibit Access reimbursement for those procedures, and authorize the attorney general to enforce compliance. Representative Lisa Fink, the sponsor, argued insufficient evidence exists for safety and effectiveness of puberty blockers and cross‑sex hormones in minors and cited medical risks and claims that some foreign countries had pulled back from pediatric treatments.
Testimony was sharply divided and emotional. Supporters included Chloe Cole (a detransitioner who described serious long-term harms), Dr. Ivan Abduche (retired physician who criticized WPATH guidance), Edward Hidako (a father who said his son was sterilized during care in California) and others who argued the bill protects children from irreversible interventions. Opponents included Jean Woodbury of the ACLU, clinicians and transgender people who argued the bill discriminates, undermines the patient‑physician relationship, and could jeopardize care; multiple members cited national medical associations urging individualized clinical decision‑making. Committee members asked detailed questions about definitions (for example, "threatened violation") and clinical thresholds; sponsor and supporters clarified they intended ‘‘threatened’’ to mean an actual recommendation to pursue transition‑related medical interventions rather than symbolic expression.
After extended questioning and testimony on both sides, the vice chair moved the bill; the roll call resulted in 7 ayes and 5 nays, giving HB 20‑85 a due‑pass recommendation from committee.